Top Page
BrainChip Holdings
(OTC:BRN)
BrainChip Holdings (BRN) vs. iShares MSCI Australia ETF (EWA)
BrainChip Holdings Business Overview & Revenue Model
BrainChip Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.31M | 398.01K | 232.00K | 5.07M | 1.59M | 120.83K |
| Gross Profit | 70.19K | -134.91K | 91.44K | 4.59M | 1.30M | -195.72K |
| EBITDA | -22.21M | -23.67M | -27.99M | -21.41M | -20.65M | -11.02M |
| Net Income | -22.27M | -24.43M | -28.88M | -22.09M | -20.98M | -26.82M |
Balance Sheet | ||||||
| Total Assets | 19.55M | 23.05M | 20.18M | 29.18M | 23.78M | 22.65M |
| Cash, Cash Equivalents and Short-Term Investments | 13.46M | 20.00M | 14.34M | 23.12M | 19.37M | 19.14M |
| Total Debt | 1.00M | 1.17M | 1.70M | 2.05M | 1.85M | 497.23K |
| Total Liabilities | 4.31M | 3.22M | 3.35M | 5.46M | 4.84M | 5.93M |
| Stockholders Equity | 15.24M | 19.83M | 16.83M | 23.72M | 18.94M | 16.72M |
Cash Flow | ||||||
| Free Cash Flow | -14.61M | -15.96M | -17.66M | -19.88M | -13.94M | -11.22M |
| Operating Cash Flow | -14.55M | -15.88M | -17.53M | -19.69M | -13.69M | -11.17M |
| Investing Cash Flow | -60.61K | -72.65K | -132.60K | -127.22K | -265.55K | -44.24K |
| Financing Cash Flow | 17.65M | 22.60M | 8.84M | 17.59M | 14.69M | 21.48M |
BrainChip Holdings Technical Analysis
BrainChip Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | AU$87.35M | 10.96 | 10.79% | 4.76% | 14.59% | -11.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | AU$965.95M | -23.62 | -50.48% | ― | 333.23% | 10.83% | |
53 Neutral | AU$1.08B | 380.47 | <0.01% | ― | -29.99% | -66.84% | |
50 Neutral | AU$20.61M | ― | -112.59% | ― | ― | -67.74% | |
38 Underperform | AU$392.74M | ― | -149.70% | ― | 503.29% | 11.46% | |
23 Underperform | AU$181.10M | -22.17 | ― | ― | -100.00% | 44.26% |
BrainChip Holdings Corporate Events
BrainChip Holdings has released a capital raise presentation, which includes forward-looking statements about the company’s future performance and financial outlook. The presentation highlights the potential risks and uncertainties associated with these projections and advises investors not to place undue reliance on them. This announcement is part of BrainChip’s strategic efforts to secure funding for its ongoing business strategies and could impact its market positioning by potentially enhancing its financial stability and operational capabilities.
BrainChip Holdings Ltd has announced a proposed issue of 200 million ordinary fully paid securities, scheduled for November 17, 2025. This move is part of the company’s strategy to enhance its financial position and potentially expand its market presence, reflecting its commitment to growth and innovation in the AI sector.
BrainChip Holdings Ltd has announced a new securities purchase plan, proposing to issue up to 11,428,572 ordinary fully paid securities. This move is part of the company’s strategy to strengthen its financial position and support its ongoing operations and growth initiatives. The offer is set to close on November 28, 2025, with the issue date scheduled for December 4, 2025. This issuance is expected to enhance BrainChip’s market positioning and provide additional resources to capitalize on opportunities in the AI and machine learning sectors.
BrainChip Holdings Ltd has announced a capital raising initiative, comprising a fully underwritten institutional placement of A$35 million and a non-underwritten share purchase plan to raise up to an additional A$2 million. The funds will be used to accelerate the commercialisation of the Akida 2.0 technology platform, expedite the development of edge AI products, fund generative AI research, and advance chip architecture design. This initiative aims to strengthen BrainChip’s leadership in edge AI and neuromorphic computing, unlocking new commercial opportunities and driving scalable innovation.
BrainChip Holdings Ltd has requested a trading halt on its securities pending an announcement related to a proposed capital raising. This move is aimed at ensuring an orderly market while the company finalizes arrangements for the capital raising and prepares the necessary announcement. The halt is expected to last until the announcement is made or normal trading resumes on November 10, 2025. This development could have significant implications for BrainChip’s financial strategy and market positioning.
BrainChip Holdings Ltd announced a change in the director’s interest, with Duy-Loan Thi Le acquiring 154,321 ordinary shares through the vesting of restricted stock units. This adjustment reflects a strategic alignment of the director’s interests with the company’s growth, potentially impacting shareholder perceptions and market positioning.
BrainChip Holdings Ltd announced the issuance of 154,321 ordinary fully paid securities, effective November 3, 2025. This move signifies the conversion of unquoted options or other convertible securities, potentially impacting the company’s capital structure and providing new opportunities for stakeholders in the tech industry.
In its latest quarterly report, BrainChip Holdings Ltd announced a cash balance of $13.9 million and highlighted a strategic shift to commence volume production of its AKD1500 neuromorphic processor. This decision is driven by strong customer engagement and successful testing, proving the chip’s capabilities in real-world AI applications. The company has also advanced a strategic supply agreement with Parsons Corporation for defense applications and expanded its distribution partnership with DigiKey to broaden its reach in the AI hardware market. These developments position BrainChip as a key player in the next generation of intelligent edge AI devices, enhancing its role from a hardware provider to a full-stack AI partner.
BrainChip Holdings Ltd announced that its CEO, Sean Hehir, will present at the Semiconductor Australia 2025 event in Sydney. The presentation will focus on the integration of AI in silicon, the transition from cloud to edge AI, and market opportunities in Edge and Generative AI. BrainChip’s Akida platform is highlighted for its ultra-low-power edge AI capabilities across sectors like healthcare, defense, and space, positioning the company as a key player in the evolving semiconductor industry.
BrainChip Holdings Ltd. has released a presentation detailing projections and estimates about its future financial performance and market growth. The company emphasizes that these projections are based on assumptions and are subject to significant uncertainties, highlighting the potential impact on its operations and industry positioning.
BrainChip Holdings Ltd has announced the commencement of the tape-out process for its AKD1500 reference design, moving towards volume production in response to strong customer demand. This strategic move aims to capitalize on the growing need for low-power, on-device AI solutions, with production parts expected by late Q3 2026. The AKD1500, leveraging BrainChip’s Akida technology, offers energy-efficient, real-time edge processing, crucial for battery-powered devices. The company’s expansion into full-stack AI solutions positions it as a comprehensive partner, enhancing its market positioning and accelerating the adoption of its technology across various high-growth markets.
BrainChip Holdings Ltd addressed a price query from the ASX, confirming that they are unaware of any undisclosed information that could explain recent trading activity in their securities. The company assured compliance with listing rules and confirmed that their responses were authorized according to their disclosure policy.
BrainChip Holdings Ltd announced the issuance of 350,000 restricted stock units, as part of its ongoing strategy to manage equity securities. This move is likely to impact the company’s financial structure and could influence stakeholder perceptions, reflecting its commitment to strategic growth and operational expansion.
BrainChip Holdings Ltd has announced the issuance and conversion of unquoted equity securities, totaling 5,737,074 ordinary fully paid shares. This move is part of the company’s strategic financial operations, potentially impacting its market position by increasing its share capital and providing additional resources for growth and development.
BrainChip Holdings Ltd announced the cessation of 17,544,195 restricted stock units due to the lapse of conditional rights that were not satisfied. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and strategic focus.
BrainChip Holdings Ltd announced the issuance of 5,070,000 restricted stock units under an employee incentive scheme. These securities are not quoted on the ASX and are subject to transfer restrictions, reflecting the company’s strategy to incentivize and retain talent, potentially impacting its operational dynamics and stakeholder engagement positively.
BrainChip Holdings Ltd announced the issuance of 10,000,000 fully paid ordinary shares to the Trustee of the BrainChip Equity Plan Trust to administer the Equity Plan. This move aligns with the company’s compliance with the Corporations Act, ensuring transparency and adherence to regulatory requirements. The issuance of shares without disclosure to investors reflects BrainChip’s strategic approach to managing its equity and supporting its growth initiatives.
BrainChip Holdings Ltd has announced the issuance of 10,000,000 ordinary fully paid shares to the trustee of the company’s Equity Incentive Plan. This move is part of the company’s strategy to manage its equity incentive plan, potentially impacting its market positioning by aligning the interests of stakeholders and employees with the company’s growth objectives.